CES2, ABCG2, TS and Topo-I Primary and Synchronous Metastasis Expression and Clinical Outcome in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Regimen

By Silvestris Nicola   Simone Giovanni   Partipilo Giulia   Scarpi Emanuela   Lorusso Vito   Brunetti Anna Elisabetta   Maiello Evaristo   Paradiso Angelo   Mangia Anita  

International Journal of Molecular Sciences, Vol. 15, Iss. 9, 2014-09 ,pp. : 15767-15777

MDPI

Access to resources Recommend Favorite

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 138-144

Karger

Access to resources Recommend Favorite

Phase I/II Study of 24-Hour Infusion of Irinotecan Combined with Oral UFT for Metastatic Colorectal Cancer

By  

Chemotherapy, Vol. 54, Iss. 2, 2008-02 ,pp. : 140-146

Karger

Access to resources Recommend Favorite

Sequential Treatment with Irinotecan and Doxifluridine: Optimal Dosing Schedule in Murine Models and in a Phase I Study for Metastatic Colorectal Cancer

By  

Chemotherapy, Vol. 51, Iss. 1, 2005-04 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse

By Al-Temaimi Rabeah A.   Tan Tuan Zea   Marafie Makia J.   Thiery Jean Paul   Quirke Philip   Al-Mulla Fahd  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-04 ,pp. : 598-598

MDPI

Access to resources Recommend Favorite